Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With ...
Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback